181 related articles for article (PubMed ID: 21766546)
1. Emerging concepts in monoclonal gammopathy of undetermined significance.
Freytes CO
Bol Asoc Med P R; 2010; 102(4):43-6. PubMed ID: 21766546
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance: a consensus statement.
Berenson JR; Anderson KC; Audell RA; Boccia RV; Coleman M; Dimopoulos MA; Drake MT; Fonseca R; Harousseau JL; Joshua D; Lonial S; Niesvizky R; Palumbo A; Roodman GD; San-Miguel JF; Singhal S; Weber DM; Zangari M; Wirtschafter E; Yellin O; Kyle RA
Br J Haematol; 2010 Jul; 150(1):28-38. PubMed ID: 20507313
[TBL] [Abstract][Full Text] [Related]
3. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
Madan S; Greipp PR
Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
[TBL] [Abstract][Full Text] [Related]
4. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
5. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
Bird J; Behrens J; Westin J; Turesson I; Drayson M; Beetham R; D'Sa S; Soutar R; Waage A; Gulbrandsen N; Gregersen H; Low E;
Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
[No Abstract] [Full Text] [Related]
6. Monoclonal gammopathy of undetermined significance.
Kyle RA
Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
[TBL] [Abstract][Full Text] [Related]
8. Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
Kristinsson SY; Björkholm M; Landgren O
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):187-90. PubMed ID: 23490991
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
[TBL] [Abstract][Full Text] [Related]
10. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
Castillo JJ; Gertz MA
Leuk Lymphoma; 2017 Apr; 58(4):773-780. PubMed ID: 27546465
[TBL] [Abstract][Full Text] [Related]
11. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
Ruiz-Delgado GJ; Gómez Rangel JD
Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
14. Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression.
Li R; Du J; Hou J
Hematology; 2015 Jan; 20(1):11-7. PubMed ID: 24670051
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice. Monoclonal gammopathy of undetermined significance.
Bladé J
N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
[No Abstract] [Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathies of undetermined significance called "MGUS"].
Clément F
Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Correa JG; Cibeira MT; Tovar N; Isola I; Pedrosa F; Díaz T; Lozano E; Magnano L; Rosiñol L; Bladé J; Fernández de Larrea C
Br J Haematol; 2017 Dec; 179(5):849-851. PubMed ID: 27605200
[No Abstract] [Full Text] [Related]
19. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
Berenson JR; Yellin O
Clin Lymphoma Myeloma; 2009 Aug; 9(4):311-5. PubMed ID: 19717382
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]